Squamous cell carcinoma (SCC) is an uncommon histologic subtype of bladder cancer with limited data on treatment patterns, outcomes, and prognostic factors.
Furthermore, administrative databases allow the observation of practice patterns outcomes associations in large numbers of unselected patients.
Against this background, we aimed to describe the demographics, drug treatment patterns, outcomes and costs of patients with CTEPH treated under everyday practice conditions in six European countries.
The aims of the present study were to evaluate the treatment patterns, outcomes, and safety of sorafenib for routine treatment of Korean patients with advanced HCC with hepatic decompensation and compensated liver function.
Several useful predictions have been obtained from such in-silico models [ 23, 24], including predicting the consequences of gene deletions, optimal growth patterns, outcomes of adaptive evolution and more.
Finally, little attention has been paid to the identification and measurement of initial conditions, that is, the potentially confounding factors and effect modifiers of the practice patterns outcomes relationship.
Similarly, the model needs to be tested in clinical settings to determine its impact on practice pattern, outcome and costs of care for patients with WAD (impact analysis) [ 42].
The main treatment pattern outcomes were discontinuation, switching, augmentation and initiation of insulin therapy.
The main treatment pattern outcomes were discontinuation, switching, augmentation and initiation of insulin.
